Sign Up to like & get
recommendations!
1
Published in 2022 at "Cellular and Molecular Life Sciences"
DOI: 10.1007/s00018-021-04111-2
Abstract: Conventional angiogenic factors, such as vascular endothelial growth factor (VEGF), regulate both pathological and physiological angiogenesis indiscriminately, and their inhibitors may elicit adverse side effects. Secretogranin III (Scg3) was recently reported to be a diabetes-restricted…
read more here.
Keywords:
pathological physiological;
angiogenesis;
scg3;
secretogranin iii ... See more keywords